Skip to content
Life sciences consumables, equipment and services, delivered across Saudi Arabia.
Human Frizzled 7 ELISA Kit (HUFI07885)
  • Human Frizzled 7 ELISA Kit (HUFI07885)
Assay Genie

Human Frizzled 7 ELISA Kit (HUFI07885)

Price on request

SKUPriceQuantity
HUFI07885

Price on request

Description

This description has not been verified against the manufacturer's datasheet. Check the datasheet before you order, or ask us to confirm a specification. Ask us to confirm

Frizzled 7 (FZD7) is a seven-transmembrane GPCR-class receptor that mediates Wnt ligand binding and activates downstream β-catenin signaling cascades. The Assay Genie Human Frizzled 7 ELISA Kit provides quantitative measurement of FZD7 protein levels in human-derived research specimens, supporting oncology, developmental biology, and stem cell investigations where aberrant Wnt activity drives disease phenotypes.

FZD7 is implicated in multiple solid tumor types including colorectal, gastric, hepatocellular, and triple-negative breast cancer, where elevated receptor expression correlates with tumor proliferation, invasion, and poor prognosis. Researchers use FZD7 quantification to study epithelial-mesenchymal transition, planar cell polarity, and axis formation during embryonic development. The kit also supports studies of GPCR-family oncogenic drivers and biomarker discovery programs targeting the Wnt pathway.

Assay Genie manufactures this ELISA Kit as a complete plate-format package containing 96 Assays, intended for research use only. Each plate supports standard curve generation alongside unknown sample determinations, enabling reproducible receptor-level interrogation across treatment conditions, time-course experiments, and comparative disease versus normal tissue analyses. Laboratory workflows can examine ligand-induced receptor modulation, frizzled family crosstalk, and downstream β-catenin stabilization events.

The product is appropriate for translational research programs evaluating aberrant Wnt signaling in solid tumors, academic investigations of developmental patterning, and pharmaceutical screening efforts exploring Wnt pathway inhibitors and FZD7-targeted therapeutics.